Adjuvant Olaparib Improves Disease-Free Survival in Early, High-Risk, BRCA-Mutated, HER2- Breast Cancer

Oncologist. 2021 Jun 21. doi: 10.1002/onco.13863. Online ahead of print.NO ABSTRACTPMID:34152054 | DOI:10.1002/onco.13863

Source: The Oncologist - June 21, 2021 Category: Cancer & Oncology Source Type: research